Research Feed
IQVIA 10-K: Real Margin Compression, Overdone Selloff
IQVIA's FY2025 10-K confirms margin compression is real and AI risk is formally acknowledged — but at 11.85x forward P/E with RSI 14.2, the market has overshot fundamental deterioration by a wide margin. Three findings matter: 1. R&D margin compression is happening now — R&D Solutions segment profit
RELX Q4 2025: STM Upgrade + 90% Idio Variance at 14x Forward P/E
RELX delivered strong Q4 2025 results (7% revenue, 9% profit, 10% EPS, 99% cash conversion) into a stock crushed 38% on AI disruption fear triggered by Anthropic's Claude Cowork launch. At $31.06, the stock trades at 14x forward P/E with analyst targets at $51.50 (+66% upside, 12-month horizon). The